We have studied a woman with an apparent receptor-mediated resistance to cortisol on the basis of elevated 24-h mean plasma cortisol levels and increased urinary free cortisol. Plasma ACTH concentrations were normal but she was resistant to adrenal suppression by dexamethasone. No stigmata of Cushing's syndrome were seen. To study the proposed end-organ resistance to cortisol, we examined the glucocorticoid receptor (GR) in lymphocytes and in fibroblasts from this patient and from her son. Several molecular properties of the GR of lymphocytes from the patient were indistinguishable from that of normal control subjects. In thermolability assays, however, the patient's GR as well as her son's GR showed a striking heat sensitivity at 400 and 450C when compared with GR from normal persons. In addition, data from the thermolability assays correlated well with the lack at 450C of dexamethasone-induced decrease in in vitro IHlthymidine incorporation into lymphocytes derived from both patients.
Introduction
Glucocorticoid resistance in humans, characterized by hypercortisolism without the features of Cushing's syndrome, was first described in 1976 by Vingerhoeds et al. (1) in a 50-yr-old man with advanced hypertension and hypokalemic alkalosis. Subsequent biochemical (2) and genetical (3) studies indicated that the patient suffered from a rare familial syndrome where the primary cortisol resistance was due to a glucocorticoid receptor (GR)' present at the normal concentration but with decreased affinity for cortisol.
In this report, we describe a woman with primary glucocorticoid resistance in whom the end-organ insensitivity to cortisol apparently is not due to a decreased concentration or ligand affinity of the receptor. However, the GR of the woman as well as ofher son, who did not show so pronounced clinical symptoms as those of his mother, displayed an increased thermolability, a phenomenon also seen with androgen receptors from patients with the testicular feminization syndrome (4).
Case report
The patient was 46 yr old when she consulted her local hospital for symptoms of edema, red, swollen hands, and a pronounced fatigue. She had no previous history ofdisease. The menopause Receivedfor publication 4 April 198S and in revisedform 24 June 1986.
1. Abbreviations used in this paper: GR, glucocorticoid receptor, TA, triamcinolone acetonide. had occurred 3 yr earlier. The patient's mother had also had an early menopause. The patient's seven younger sisters were healthy. Her father had died from a cerebral hemorrhage at the age of 61 yr. The patient's mother suffered from diabetes, hypertension, and cardiac insufficiency. The patient's only child, a son 29 yr old, had had periods of inexplicable fatigue that had made him stay home from school and work.
The patient was a cleaning assistant who had worked halftime for the previous 10 yr owing to a tendency to fatigue, in this case a symptom including an increased need of sleep and a feeling of chilliness and of feebleness. During the course of investigation the cutaneous changes and edema vanished when a recently introduced cleaning detergent was avoided. The physical examination revealed nothing pathological. Her weight was 48 kg over the past several years and her height 166 cm. Her blood pressure was 100-105/60-65 mmHg, with no orthostatism. There were no indications of anorexia or mental depression. The findings of her complete blood count, electrolytes, erythrocyte sedimentation rate, serum Fe, cholesterol, triglycerides, albumin, endogenous creatinine clearance, liver function tests, thyroid-stimulating hormone, triiodothyronine, thyroxine, prolactin, luteinizing hormone, follicle-stimulating hormone, and testosterone were all normal for her age.
Because of the patient's slim features, Addison's disease was suspected but three urinary 24- h cortisol values were found to be two-to four-fold increased. The patient was referred to the Department ofEndocrinology, Karolinska Hospital, Stockholm to determine whether she had Cushing's syndrome.
Plain x-rays of the skull and pituitary fossa, cisternography, and 2 yr later, computed tomography scanning of the pituitary region yielded normal results as did sonography and computed tomography scanning of the adrenals, pancreas, and liver. Skeletal x-rays showed no signs of osteoporosis.
Since the detection ofhypercortisolism, the patient has been observed for 4 yr during which her clinical features (no stigmata of Cushing's syndrome and continuing complaints of chilliness and of fatigue) have not changed. She has continued to work half-time as a cleaner. The 24-h cortisol excretions have constantly been two-to fourfold increased during the periods when she has felt completely healthy as well as during periods offatigue.
Three 24-h urine samples from her son were collected for the determination of cortisol. The patient has not received a trial ofglucocorticoid treatment in order to see whether her symptoms would improve.
Methods
In this study healthy blood donors were used as controls. In each control experiment, 100 ml of peripheral blood was used from which the lymphocytes were isolated.
Isolation ofhuman lymphocytes D-glucose, pH 7.4) and layered on a discontinuous Ficoll-Paque gradient (Pharmacia, Uppsala, Sweden) in siliconized 50-ml centrifuge tubes. After centrifugation at 400 g in a Beckman TJ6 centrifuge (Beckman Instruments, Inc., Palo Alto, CA) for 30 min at 18'C, the layer containing lymphocytes was withdrawn. The lymphocytes were washed twice by resuspension in the balanced salt solution and centrifugation at 100 g for 10 min at 18'C. More than 95% of the lymphocytes were viable as determined by the trypan blue exclusion test and counting in a hemocytometer (Barker, Kebo Laboratory, Stockholm) (5, 6) . Cells that were not used immediately were frozen and stored at -70'C.
Preparation ofcytosol
In order to eliminate the influence ofendogenous steroids in the Scatchard analysis we used the procedure described by Rosner and Polimeni (7) . They showed that during 20 h at 00C, soluble enzymes in the cytosol almost completely metabolize cortisol to products which do not interfere with the receptor binding of [6,7-3H] triamcinolone acetonide (3H-TA: specific activity 300 kBq/mmol, Amersham Searle Corp., Amsterdam, the Netherlands). At the end ofthis time, specifically bound 3H-TA (see below) is a valid measure ofthe total receptor concentration. Lymphocytes isolated from fresh blood were kept in a medium (RPMI 1640) without serum, supplemented with L-glutamine (2 mM), bensyl-penicillin (400 IU/ml), and streptomycin (0.2 mg/ml), for 24 h at 0C. The lymphocyte suspension was then centrifuged and the pellet was stored at -70°C until used for the preparation of cytosol.
Fibroblasts from established cell cultures (described below) growing in monolayers were kept in a medium (minimal essential medium) without serum, supplemented with L-glutamine (2 mM), bensyl-penicillin (400 IU/ml), and streptomycin (0.2 mg/ml), for 24 h at 37°C. The medium was then removed, the monolayers were rinsed, the cells were harvested with trypsin-EDTA, and the resulting cell suspension was centrifuged. The cell pellet was stored at -70°C until used for the preparation of cytosol.
Human lymphocytes and fibroblasts stored at -70°C were lysed by thawing at 4°C. Cells were then homogenized in ice-cold ETG buffer (1 mM EDTA, 20 mM Tris-HCI, pH 7.8, 10% (wt/vol) glycerol, and 2 mM dithiothreitol) in an all-glass Dounce B homogenizer using 20 manual strokes. The homogenates were centrifuged at 100,000 g for 30 min at 0°C in a Beckman type 50 SW rotor (Beckman Instruments, Inc., Palo Alto, CA). The clear supernatants were used as cytosol. The cytosol was incubated with 100 nM 3H-TA at 0°C for 4 h in all experiments except in the case of the Scatchard analysis, where the incubation period was 24 h. A 200-fold molar excess of unlabeled TA was used in order to determine specific (i.e., displaceable) binding.
Whole cell binding
The binding capacity of mononuclear leucocytes was determined by incubating lymphocytes with medium without serum for 24 h and then washing the cells twice with phosphate-buffered saline before adding various concentrations of 3H-TA in 2 ml of medium without serum and with or without a 200-fold molar excess of nonradioactive TA. Each incubation contained 106 cells/ml medium and was performed at 37°C in a 5% CO2 incubator for 90 min. The medium was removed by centrifugation, the cells were washed twice with phosphate-buffered saline, and harvested on glass-fiber filter-papers for measurement of radioactivity. Binding capacity, expressed as number of binding sites per cell, and apparent dissociation constant were calculated according to Scatchard (8) .
Cell culture
Fibroblasts were established from explants of skin. Punch biopsies, 4 mm diam, were taken from the patient and her son and from six controls. Fibroblast strains and cell cultures were established according to Ham (9 
Isoelectric focusing in polyacrylamide gel
As a further means to quantitate the GR we used isoelectric focusing in polyacrylamide gel according to Hansson et al. (6) . Polyacrylamide gels for isoelectric focusing were prepared as described by Wrange (I 1). All samples were applied in acrylic glass frames and analyzed simultaneously. The isoelectric focusing was performed at a current of 20 mA and a voltage of 1,200 V. The total running time was 90 min. The gel strip corresponding to the sample was cut into 0.5-cm slices and transferred to counting vials. After addition of 5 ml of scintillator fluid to the vials, the radioactivity in the slices was extracted at 60°C for 45 min, and the radioactivity was measured in a liquid scintillation counter. Hansson et al. (6) also demonstrated a better recovery of total steroid-receptor complexes if the isoelectric focusing was carried out after limited proteolysis of the receptor. In the present experiments trypsin (81 U/mg of protein, i.e., 0.8 Ug/(A2M-A310) unit, see below) was used (10) and the reaction was carried out for 30 min at 10°C.
Protein determination
An estimation of the cytosolic protein concentration was obtained by expressing the difference in optical density at 280 nm and 310 nm, (A2m-A310). Protein was also determined according to Lowry et al. (12) . Receptor concentrations were expressed as femtomoles per milligram of protein.
DNA-cellulose chromatography DNA-cellulose was prepared as described by Alberts and Herrick (13) . Cytosolic samples (1 ml) were labeled for 4 h at 0°C using 100 nM final concentration of 3H-TA. Labeled cytosol was treated with dextran-coated charcoal to remove unbound steroid (10) and activation of the steroidreceptor complex was performed by incubation at 25°C for 30 min. The incubation mixture was cooled on ice and applied on a 1-ml DNAcellulose column. The column was incubated with the sample for 15 min and then washed with five to six column volumes of ETG buffer. The column was eluted with 5 ml ofETG buffer containing 0.3 M NaCG. Aliquots, 100 Ml were taken from each fraction and counted for radioactivity.
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Gelfiltration
Gel filtration was carried out on Agarose A-1.5 (Bio-Rad Pharmacia, Uppsala). Samples of 3 ml were applied on the column (87 X 1.5 cm) and chromatographed at 10 cm/h in ETG buffer; 0.15 M KCl; 0.02% (wt/vol) NaN3; 20 mM molybdate. Molybdate was added to the sample 30 min after the addition of 3H-TA and 1 h before application to the column. The column was calibrated using the following proteins: horse spleen ferritin, 14C-methylated bovine serum albumin, '4C-methylated catalase, and '4C-methylated whale skeletal muscle myoglobin. The Stokes radii of these proteins are 6.15, 3.59, 5.20, and 2.01 nm (14, 15) , respectively.
Hormone assays
Serum cortisol (16) , urinary free cortisol (17) , ACTH (18) , aldosterone (19) , insulin (20) , and C peptide (21) were determined by radioimmunoassays. Cortisol-binding globulin and sex hormone-binding globulin were determined by equilibrium dialysis (22) . The urinary excretion of glucocorticoid precursors and metabolites was determined by high-pressure liquid chromatography (23) .
Assays for temperature stability ofGR Whole cell assay. Fibroblasts were grown in monolayer cultures as described above. One day prior to the experiment the monolayers were rinsed with 2 ml of phosphate-buffered saline and 3 ml of fresh medium (minimal essential medium) without serum were added. In experiments assessing binding at 400 and 450C, the monolayers were preincubated at 400 or 45°C for 60 min in medium without serum. The medium was then removed, and medium containing 100 nM 3H-TA ± a 200-fold molar excess of unlabeled TA (warmed to indicated temperatures) was added. The monolayers were then incubated for 60 min in the CO2 incubator at 400 or 45°C, respectively. In experiments assessing binding at 300 and 35°C, medium with 3H-TA ± a 200-fold molar excess of unlabeled TA (warmed to 300 or 350C) was added to the monolayers, and the monolayers were incubated in a CO2 incubator at 300 or 350 for 60 min. After incubation at the indicated temperatures, the medium was removed, the monolayers were rinsed twice, and the cells were harvested with trypsin-EDTA, then centrifuged and homogenized before aliquots were taken for measurement ofradioactivity 
Results
Glucocorticoid tests. Diurnal serum cortisol, which was analyzed on three occasions, showed slightly elevated levels and a blunted rhythm (Fig. 1 a) (Fig. 1 b) .
The low-and high-dose oral dexamethasone suppression test, illustrated in Table I Fig. 2 , where the inset shows data replotted according to Scatchard (8) . The binds to a single class of receptor sites of uniform ligand affinity, both in lymphocytes from the patient and in lymphocytes from the controls. The total number ofbinding sites per cell was 1,600 and 5,400 (patient: two determinations) and 3,500±1,300 (controls: n = 8). The dissociation constants were 4.2 and 3.9 (patient: two determinations) and 4.1±2.0 nM (controls: n = 8). The son showed similar GR characteristics as assayed in lymphocytes. The total number of binding sites per cell was 2,000 and 1,500 (two determinations) and the dissociation constant was 4.5 and 5.3 nM (two determinations). In addition, the binding capacity of cultured skin fibroblasts, expressed either as femtomoles per milligram of protein in cytosol or sites per cell (RO) in whole cells did not reveal any differences between the two patients and the controls. In all cases, the total number of binding sites per cell was approximately 40,000 and the apparent dissociation constant 5.0 nM. The results from our studies on the characteristics of the GR from the patient, her son, and controls are summarized in Table II . From these results it is obvious that no differences exist conperning receptor-ligand affinity or number of specific ligandbinding sites in lytnphocytes or fibroblasts when comparing the two patients with the controls.
According to Lippman and Barr (25) , no differences were seen between subpopulations of human mononuclear cells with regard-to KD values or number ofspecific glucocorticoid binding sites per cell. Therefore, the unfractionated lymphocytes isolated with Ficoll-Paque should contain a homogeneous pool of GR.
DNA-cellulose chromatography. The DNA-binding capacity of lymphocytic GR was studied using DNA-cellulose chromatography of thermally activated receptor (26) . In order to elute both the 6-and 3.3-nm receptor forms, previously described for the rat liver GR and shown to elute at 0.17 and 0.25 M NaCl, respectively (27) , DNA-cellulose was first washed with five to six column volumes of ETG buffer, giving the flow-through containing nonactivated GR, and then eluted with 5 ml ETG buffer with 0.3 M NaCl. No significant difference in total DNA-cellulose binding of activated lymphocytic GR from the patient as compared to the controls was found (Table III) .
Gelfiltration. In order to compare further the GR from the patient and controls, respectively, agarose filtration ofmolybdatestabilized cytosolic ligand-receptor complex was carried out. GR from human lymphocytes, particularly in its free form, is generally unstable in cytosol, probably due to a high concentration of proteolytic enzymes in this type of preparation (28) . In order to stabilize the receptor during long chromatographic procedures, gel filtration was carried out in the presence of molybdate. In conclusion, no difference in size between GR complexes from the patient and the controls, respectively, was found.
Temperature stability. In the cytosolic assay very low levels ofspecific 3H-TA binding, 2.2±1.9 and 0.3±0.5 fmol/mg protein, respectively, were found at 400 and 450C in lymphocytes from the patient. In controls, on the other hand, the 95% confidence interval for specific binding at 40'C was 17.8-66.9 fmol/mg protein and at 45°C 16.1-22.7 fmol/mg protein (Fig. 3 c) (Fig. 3 a) . The (Fig. 3 b) . In controls, the 95% confidence In mixed cytosolic samples from a control and the two patients specific binding was detectable even at 45°C, indicating that the disappearance of binding in samples from the patients at elevated temperatures was not due to the activation of proteases (Fig. 4 a and b) . Furthermore, addition of protease inhibitors to cytosolic incubations did not alter the thermolability profiles of specific 3H-TA binding for any of the two patients (data not shown). We also investigated the effect of lowering the temperature used in the monolayer binding assay to 25°C after a preincubation at 45°C for 60 min. In these experiments both patients showed a reversible decrease in specific binding at elevated temperature (data not shown). Taken together, these results indicate the presence of a thermolabile GR in cells from the (Table V) . At 45°C, no inhibition was observed in either patient; these results are in agreement with the loss of specific 3H-TA binding at these temperatures in cells from the patients (cf. above).
Discussion
The patient under study showed an apparent end-organ insensitivity to cortisol. Despite signs of chronic endogenous hypercortisolism-increased serum and urinary cortisol, altered excretory profiles ofcortisol metabolites, hyperreactive adrenal response after metyrapone administration, and decreased cortisol Figure 4 . Analysis of proteolytic activity. Cytosol was prepared as described in Methods. 0.5 ml of 3H-TA-labeled cytosoI from (n) a control was mixed at indicated temperatures with 0.5 ml of unlabeled cytosol from (A) the mother or with 0.5 ml of unlabeled cytosol from (o) the son. After incubation for 60 min, the mixtures were treated with dextran-coated charcoal and centrifuged and aliqots were taken for measurement of radioactivity. Using the same cytosolic preparations, specific binding at 300 and 450C was determined by incubating 1 Temp.(C) Figure 3 . Effect of elevated temperature on specific binding of 3H-TA in lymphocytes and fibroblasts from (A) the patient, (o) her son, and (*) controls. At each temperature specific 3H-TA-binding capacity was determined on triplicate aliquots of cytosol or wells of monolayers, as described in Methods, and the mean±SD was calculated from these three incubations. This procedure was repeated for each of the 10 controls and a total mean±SD was calculated for each temperature. For the patient and her son specific 3H-TA-binding capacity wa's determined in the same manner and repeated twice. inhibition by exogenous glucocorticoids-she lacked the classical features of Cushing's syndrome. In contrast, she had signs and symptoms reminiscent of Addison's disease, namely, low body weight, low blood pressure, and fatigue. There was no clear evidence of advanced adrenal hyperplasia: sonography and computed tomography scanning visualized adrenal glands ofnormal size. Diurnal plasma ACTH was within the normal range.
Thus, in this patient the peripheral insensitivity to cortisol was not associated with the secondary, ACTH-dependent increased secretion of mineralocorticoids found in the previously reported case (2) with very advanced cortisol resistance and with cortisol levels similar to those of our patient. This indicates the existence ofsubgroups ofprimary eortisol resistance with varying compensatory mechanisms. Because of the relatively small number of family members investigated (cf. Fig. 5 ) no pattern (1) . These authors postulated a hyposensitivity to glucocorticoid action in a hypertensive, hypokalemic, but otherwise healthy male patient. The patient had a very high cortisol production rate with elevated plasma ACTH. Further studies on the cortisol resistance of this patient were published in 1982 by Chrousos et al. (2, 3) , this time with regard to the ligand affinity of GR as well as to the GR number in white blood cells and fibroblasts. In contrast to our findings, these authors reported a decreased ligand affinity and a reduced receptor number, concluding that the cortisol resistance was due to an abnormal GR with decreased cortisol affinity.
Receptor-related glucocorticoid resistance because of "activation-labile" receptor complexes has been reported in human mutant lymphoma cell lines (30) . Furthermore, therapy with pharmacologic glucocorticoid doses without the development of the stigmata of Cushing's syndrome has been linked with steroid resistance in receptor defective lymphocytes in patients with acute leukemia (31) . Principally, it appears that alterations in the sensitivity to glucocorticoids can be traced to biochemical lesions at the receptor level (4, 32) . In some cases, however, unresponsiveness to glucocorticoids occurs despite seemingly normal receptor functions and receptor concentration (33) . Most of these observations, our own findings, and some other reports on steroid action in humans (33, 34) imply that the clinical manifestations of steroid resistance in general are rarely, if ever, due to the absence of a steroid hormonal receptor, but are probably due to changes in the receptor molecule that prevent its normal function.
The finding of a temperature instability of GR in lymphocytes and fibroblasts from our patients suggests the presence of a minor structural abnormality in the receptor molecule. Such a minor protein abnormality has been described for enzymes in bacterial mutants in which an elevation of temperature is associated with altered growth (35) . Furthermore, in mutated mammalian cells structurally abnormal enzymes have been found to be responsible for the effects of elevated temperature on the functions ofthe cells (36, 37 ). An amino acid substitution at any position in the protein might lead to an alteration in the tertiary structure ofthe protein and consequently to altered biochemical properties.
Griffin (4) has described a thermolabile androgen receptor in cultured human fibroblasts from patients with testicular feminization. According to him, the degree offeminization was positively correlated to the biochemical alterations at the receptor level. In our case, the steady-state clinical picture was that of intermittent subtle glucocorticoid insufficiency-low weight, mild hypotension, and intermittent fatigue.
